Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Research & Development: 2016-2025

Historic Research & Development for Assembly Biosciences (ASMB) over the last 9 years, with Sep 2025 value amounting to $16.6 million.

  • Assembly Biosciences' Research & Development rose 22.73% to $16.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.8 million, marking a year-over-year increase of 17.44%. This contributed to the annual value of $55.9 million for FY2024, which is 14.38% up from last year.
  • Latest data reveals that Assembly Biosciences reported Research & Development of $16.6 million as of Q3 2025, which was up 2.87% from $16.1 million recorded in Q2 2025.
  • Assembly Biosciences' 5-year Research & Development high stood at $18.6 million for Q1 2021, and its period low was $10.8 million during Q3 2023.
  • In the last 3 years, Assembly Biosciences' Research & Development had a median value of $14.3 million in 2024 and averaged $13.9 million.
  • Its Research & Development has fluctuated over the past 5 years, first plummeted by 55.99% in 2021, then increased by 29.83% in 2024.
  • Over the past 4 years, Assembly Biosciences' Research & Development (Quarterly) stood at $14.7 million in 2021, then reached $11.0 million in 2023, then rose by 29.75% to $14.3 million in 2024, then grew by 22.73% to $16.6 million in 2025.
  • Its Research & Development was $16.6 million in Q3 2025, compared to $16.1 million in Q2 2025 and $14.9 million in Q1 2025.